300149SZSE

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Chempartner Pharmatech Co., Ltd.··6 pages

✨ AI Summary

The 2025 Annual Shareholders' Meeting of Ruizhi Pharmaceutical Technology Co., Ltd. was held on May 28, 2026. Key resolutions included the approval of the 2025 Board Work Report, Financial Settlement Report, Annual Report, Profit Distribution Plan, and several other proposals, all passing with significant majority votes. The meeting confirmed compliance with legal and regulatory requirements, ensuring the validity of the proceedings and outcomes.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Ruizhi Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.

Special Reminder:

  1. There were no rejected proposals at this shareholders' meeting.
  2. This shareholders' meeting does not involve changes to the resolutions of the previous shareholders' meeting.

I. Meeting Convening and Attendance

The 2025 Annual Shareholders' Meeting of Ruizhi Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "this meeting") was held on May 28, 2026. The Company disclosed the "Notice of the 2025 Annual Shareholders' Meeting" (Announcement No.: 2026-21) on April 29, 2026, and the "Supplementary Notice of the 2025 Annual Shareholders' Meeting" (Announcement No.: 2026-29) on May 18, 2026. Details can be found in the relevant announcements disclosed on the Giant Tide Information Network (www.cninfo.com.cn). The relevant matters are announced as follows:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.